147 related articles for article (PubMed ID: 20127132)
1. In vitro time-kill activities of ciprofloxacin alone and in combination with the iron chelator deferasirox against Vibrio vulnificus.
Neupane GP; Kim DM
Eur J Clin Microbiol Infect Dis; 2010 Apr; 29(4):407-10. PubMed ID: 20127132
[TBL] [Abstract][Full Text] [Related]
2.
Kim SE; Kim HK; Choi SM; Yu Y; Kim UJ; Darboe KS; Kang SJ; Park KH; Kang G; Kim YR; Rhee JH; Jung SI; Jang HC
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332060
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis.
Jang HC; Choi SM; Kim HK; Kim SE; Kang SJ; Park KH; Ryu PY; Lee TH; Kim YR; Rhee JH; Jung SI; Choy HE
PLoS One; 2014; 9(6):e101118. PubMed ID: 24978586
[TBL] [Abstract][Full Text] [Related]
4. Deferasirox plus ciprofloxacin combination therapy after rapid diagnosis of Vibrio vulnificus sepsis using real-time polymerase chain reaction.
Kim DM; Cho HS; Kang JI; Kim HS; Park CY
J Infect; 2008 Dec; 57(6):489-92. PubMed ID: 18930321
[TBL] [Abstract][Full Text] [Related]
5. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus.
Kim DM; Lym Y; Jang SJ; Han H; Kim YG; Chung CH; Hong SP
Antimicrob Agents Chemother; 2005 Aug; 49(8):3489-91. PubMed ID: 16048966
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of deferasirox, deferiprone, and deferoxamine on the growth and virulence of Vibrio vulnificus.
Neupane GP; Kim DM
Transfusion; 2009 Aug; 49(8):1762-9. PubMed ID: 19413741
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Third-Generation Cephalosporin Plus Ciprofloxacin or Doxycycline Therapy in Patients with Vibrio vulnificus Septicemia: A Propensity Score-Matched Analysis.
Kim SE; Shin SU; Oh TH; Kim UJ; Darboe KS; Kang SJ; Jang HC; Jung SI; Shin HY; Park KH
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007478. PubMed ID: 31188821
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Ceftriaxone, Cefepime, Doxycycline, Ciprofloxacin, and Combination Therapy for Vibrio vulnificus Foodborne Septicemia.
Trinh SA; Gavin HE; Satchell KJF
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971862
[TBL] [Abstract][Full Text] [Related]
9. Cefazolin plus minocycline against a clinical isolate of Vibrio vulnificus: in vitro and animal studies.
Tang HJ; Ko WC; Chuang YC; Chen CC; Chiang SR
Jpn J Infect Dis; 2010 Jan; 63(1):16-8. PubMed ID: 20093756
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificus.
Tang HJ; Chen CC; Lai CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
J Microbiol Immunol Infect; 2018 Feb; 51(1):76-81. PubMed ID: 27260781
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus.
Tang HJ; Chang MC; Ko WC; Huang KY; Lee CL; Chuang YC
Antimicrob Agents Chemother; 2002 Nov; 46(11):3580-4. PubMed ID: 12384368
[TBL] [Abstract][Full Text] [Related]
12. Vibrio parahaemolyticus and Vibrio vulnificus Recovered from Oysters during an Oyster Relay Study.
Elmahdi S; Parveen S; Ossai S; DaSilva LV; Jahncke M; Bowers J; Jacobs J
Appl Environ Microbiol; 2018 Feb; 84(3):. PubMed ID: 29150510
[No Abstract] [Full Text] [Related]
13. The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis.
Ibrahim AS; Gebremariam T; French SW; Edwards JE; Spellberg B
J Antimicrob Chemother; 2010 Feb; 65(2):289-92. PubMed ID: 19942619
[TBL] [Abstract][Full Text] [Related]
14. Effect of hyperbaric oxygen on Vibrio vulnificus and murine infection caused by it.
Tamura T; Iida K; Saito M; Shiota S; Nakayama H; Yoshida S
Microbiol Immunol; 2012 Oct; 56(10):673-9. PubMed ID: 22775062
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection.
Chiang SR; Tang HJ; Chang PC; Cheng KC; Ko WC; Chen CH; Chuang YC
J Microbiol Immunol Infect; 2007 Apr; 40(2):123-33. PubMed ID: 17446960
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibilities of Vibrio parahaemolyticus and Vibrio vulnificus isolates from Louisiana Gulf and retail raw oysters.
Han F; Walker RD; Janes ME; Prinyawiwatkul W; Ge B
Appl Environ Microbiol; 2007 Nov; 73(21):7096-8. PubMed ID: 17827331
[TBL] [Abstract][Full Text] [Related]
17. Ferrophilic characteristics of Vibrio vulnificus and potential usefulness of iron chelation therapy.
Kim CM; Park RY; Choi MH; Sun HY; Shin SH
J Infect Dis; 2007 Jan; 195(1):90-8. PubMed ID: 17152012
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of Vibrio vulnificus isolated from cockles and patients in Thailand.
Mala W; Chomvarin C; Alam M; Rashed SM; Faksri K; Angkititrakul S
Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):103-12. PubMed ID: 24964659
[TBL] [Abstract][Full Text] [Related]
19. Quantitative PCR and in vivo efficacy of antibiotics in the treatment of Vibrio vulnificus infection in a mouse model.
Neupane GP; Kim DM; Yun NR; Shin SH; Lim SC; Choi CH
Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2461-7. PubMed ID: 22434454
[TBL] [Abstract][Full Text] [Related]
20. Genistein inhibits Vibrio vulnificus adhesion and cytotoxicity to HeLa cells.
Oh DR; Kim JR; Kim YR
Arch Pharm Res; 2010 May; 33(5):787-92. PubMed ID: 20512479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
